Detalhe da pesquisa
1.
An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma.
Nature
; 585(7823): 107-112, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32728218
2.
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer.
Nature
; 547(7662): 222-226, 2017 07 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-28678784
3.
Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy.
Nature
; 534(7607): 396-401, 2016 06 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-27281205
4.
Generation of TCR-engineered T cells and their use to control the performance of T cell assays.
J Immunol
; 194(12): 6177-89, 2015 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25957167
5.
The right patient for the right therapy: 13th Annual Meeting of the Association for Cancer Immunotherapy (CIMT), Mainz, Germany, May 11-13, 2015.
Cancer Immunol Immunother
; 65(10): 1277-87, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27259506
6.
Cancer immunotherapy achieves breakthrough status: 12th annual meeting of the association for cancer immunotherapy (CIMT), Mainz, Germany, May 6-8, 2014.
Cancer Immunol Immunother
; 64(7): 923-30, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25548093
7.
Toward the next waves of cancer immunotherapy: 11th Annual Meeting of the Association for Cancer Immunotherapy (CIMT), Mainz, Germany, May 14-16, 2013.
Cancer Immunol Immunother
; 63(7): 749-55, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24190545
8.
Toward next-generation cancer immunotherapy: 10th annual meeting of the Association for Cancer Immunotherapy (CIMT), Mainz, Germany, May 23-25, 2012.
Cancer Immunol Immunother
; 62(5): 975-81, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23299564
9.
Development of an RNA-based kit for easy generation of TCR-engineered lymphocytes to control T-cell assay performance.
J Immunol Methods
; 458: 74-82, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29684430